Commercialized a highly effective skin cancer scanning device
Used for over 12 years and supported by more than 15 published clinical studies
The leaders in teledermatology
- What you see: The only dermatology device with standardized, fixed-focallength clinical, dermascopic, spectrophotometric views of a suspicious mole or lesion.
- It will change how you work: Seamless integration with EMR platforms allows for a more effective, efficient and collaborative workflow, resulting in improved patient outcomes.
- The professional choice: MedX designs, develops and tests in collaboration with dermatologists and primary healthcare providers. We have regulatory approvals in 35 countries including USA, Canada, Australia, Brazil, and the EU.
- Cybersecurity assurance: MedX commitment to security and safety is a top priority.
Access - Security - Results
MedX believes everyone should have quick and easy access to a dermatologist
About 1 in 4 people suffer from a skin condition - from acne to skin cancer - but few have quick and easy access to a dermatologist. With dangerous conditions like skin cancer on the rise, rigorous and regular screening is important, now more than ever. No one should have to anxiously wait for months to have a skin condition assessed, and many teledermatological tools simply aren’t reliable. That’s where MedX comes in.
MedX is the future of dermatology
The future of dermatology requires an innovative, evidence-based, end-to-end, fully secure solution that improves service delivery and patient outcomes in a cost-effective manner. That’s what MedX delivers.
How It Works: Simple Five-Step Process
- Suspicious Mole Detected
A patient or healthcare provider identifies a pigmented lesion that should be assessed by a dermatologist.
- High-Quality Image Capture by Front-Line Healthcare Providers
MedX SIAscope is a hand-held Class IIA medical device and the only image-capture technology on the market that provides clinical, dermascopic and spectrophotometric views of moles up to 2 mm below the skin’s surface. Our technology allows healthcare providers, like physicians, pharmacists and healthcare technicians, to capture perfect clinical images with 100% image integrity. Currently approximately 40% of images sent using existing teledermatology platforms cannot be successfully assessed by a dermatologist because of poor image quality. MedX’s advanced imaging technology solves this major issue facing dermatologists wanting to adopt teledermatology in their practice.
- Secure, Rapid Assessment Platform
SIAscopy on DermSecure™ is MedX’s secure, cloud-based telemedicine platform and patient management system — it captures the dermatological images from the SIAscope and forwards them for assessment by a dermatologist. These high-quality images, coupled with a patient management work flow specifically designed for dermatological e-consults, provides a rapid assessment platform for clinicians to ensure patients with suspicious pigmented lesions can be assessed swiftly by a dermatologist and the most urgent cases are given expedited treatment.
- Dermatologist Assessment
A dermatologist assesses the patient’s suspicious mole or lesion within two business days. The quality of the images facilitates an accurate assessment.
- Patient Results
Healthcare providers and patients receive secure access to detailed assessment reports and next steps. MedX stores patient’s information for 10 years, which means a patient can retrieve their patient file and take another scan of the same mole or lesion years later and compare it to previous images to see if there has been any change.
MedX deploys the latest in security measures, engages in rigorous third-party threat testing and real-time monitoring